Drug Profile


Alternative Names: Diethylamino-ethmozine; Etacizin; Ethacizine; NIK 244

Latest Information Update: 15 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kowa Pharmaceutical
  • Developer Nonindustrial source
  • Class Class Ic antiarrhythmics; Morpholines; Phenothiazines; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias

Most Recent Events

  • 15 Feb 2008 Discontinued - Clinical-Phase-Unknown for Arrhythmias in Russia (PO)
  • 15 Feb 2008 Discontinued for Arrhythmias in Japan (IV)
  • 14 Oct 1998 Profile reviewed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top